LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
27 funds hold it · Insiders net selling
Net selling: insiders sold $1.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 28, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.36 expected
Estimates as of Nov 10, 2026
EPS expected
$1.46 to $1.66
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 28, 2026 | $1.52est. $1.36 | +11.92%beat | $1.61BSEC filing | +8.9%from $1.48B |
| Jun 30, 2026Reported Aug 5, 2026 | $1.55est. $1.48 | +4.75%beat | $1.60BSEC filing | +9.6%from $1.46B |
| Mar 31, 2026Reported Apr 30, 2026 | $1.60est. $1.49 | +7.09%beat | $1.59BSEC filing | +9.0%from $1.46B |
| Dec 31, 2025Reported Feb 5, 2026 | $1.46est. $1.30 | +12.14%beat | $1.54BAlpha Vantage | +9.9%from $1.41B |
| Sep 30, 2025Reported Oct 29, 2025 | $1.23est. $1.19 | +3.36%beat | $1.48BSEC filing | +9.4%from $1.35B |
| Jun 30, 2025Reported Aug 4, 2025 | $1.40est. $1.21 | +15.70%beat | $1.46BSEC filing | +12.0%from $1.30B |
| Mar 31, 2025Reported Apr 24, 2025 | $1.37est. $1.19 | +15.13%beat | $1.46BSEC filing | +10.6%from $1.32B |
| Dec 31, 2024Reported Feb 6, 2025 | $1.17est. $1.02 | +14.71%beat | $1.41BAlpha Vantage | +12.7%from $1.25B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.54B | $1.59B | $1.60B | $1.61B |
| Cost of what it sold | $865.6M | $882.4M | $886.4M | $1.26B |
| Gross profit | $679.0M | $704.2M | $711.0M | $347.9M |
| What it spent | ||||
| Sales and admin | $82.9M | $73.4M | $77.3M | $59.9M |
| Other operating costs | $312.7M | $329.2M | $345.3M | — |
| Total operating expenses | $395.6M | $402.6M | $422.6M | $59.9M |
| What was left | ||||
| Operating profit | $283.4M | $301.6M | $288.4M | $288.0M |
| Interest on debt | $30.2M | $31.8M | $32.8M | $32.2M |
| Profit before tax | $257.7M | $288.7M | $261.6M | $257.8M |
| Tax | $55.4M | $56.4M | $53.6M | $53.4M |
| Net profit | $146.1M | $194.5M | $153.9M | $149.9M |
| EBITDA | $374.3M | $407.8M | $384.8M | $385.7M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Encompass Health announces indefinite closure of Sea Pines Rehabilitation Hospital due to flood damage
NeutralNov 6Form 8K Encompass Health Corp For: 6 November By Investing.com
NeutralNov 6Truist raises Encompass Health stock price target on strong results
BullishOct 30KeyBanc raises Encompass Health stock price target on strong earnings
BullishOct 30Encompass Health Q3 2026 Earnings Call Transcript
BullishOct 29Form 8-K Encompass Health Corp For: Oct 28
NeutralOct 29Encompass Health Corporation (EHC) Tops Q3 EPS by 16c ; Offers Guidance
BullishOct 2833 macro signals shaping EHC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
